News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Box will launch Box Automate within 24 hours to use AI agents extracting data from unstructured documents.
  • Five Star Bancorp reported Q1 net income of $18.6M, improved margins and loan growth, and raised its cash dividend to $0.25.
  • The U.S. condemned Iran's selection as an NPT review vice president, sparking a sharp diplomatic dispute at the U.N.
  • Taylor Swift filed trademarks for two short audio clips and a stage image to counter AI deepfakes and voice replication.
  • Perspective Therapeutics reported early positive Phase 1/2a radiopharma signals, prompting a cautious long trade thesis ahead of clinical catalysts.
  • Global Ship Lease scheduled its annual shareholder meeting for June 17, citing stable contracted revenue and charter durations.

Latest Articles

Tehran Seeks Inclusion of Lebanon in Any US-Israel Ceasefire Deal, Sources Say

Tehran Seeks Inclusion of Lebanon in Any US-Israel Ceasefire Deal, Sources Say

Iran has informed intermediaries that any negotiated ceasefire with the United States and Israel should explicitly cover Lebanon and halt Israeli operations against Hezbollah, six regional sources told Reuters. Tehran is reportedly still reviewing a U.S. proposal to end the month-long regional conflict but has not rejected it outright. The demand t…

Cantor Fitzgerald Entities Disclose $84.0M Sale of MBAV Shares

Cantor Fitzgerald Entities Disclose $84.0M Sale of MBAV Shares

Cantor Fitzgerald & Co. and affiliated entities reported the sale on March 24, 2026 of 7,779,865 shares of M3-Brigade Acquisition V Corp. (MBAV) at $10.80 per share, generating proceeds of $84,022,542. The Form 4 filing indicates the reporting parties no longer own 10% or more of the issuer’s Class A Ordinary Shares and that they are no longer Repo…

Lifeward Successfully Closes on Strategic Partnership with Oramed

Lifeward Successfully Closes on Strategic Partnership with Oramed

Lifeward Ltd. has completed its strategic partnership with Oramed Pharmaceuticals, acquiring Oramed's clinical-stage Protein Oral Delivery technology and gaining access to up to $47 million in capital. This partnership diversifies Lifeward's biomedical innovation portfolio and positions the company on a clear path to profitability, while also leadi…

Team Inc Director Edward J. Stenger Buys $79,991 of Stock in Two Trades

Team Inc Director Edward J. Stenger Buys $79,991 of Stock in Two Trades

Edward J. Stenger, a director at Team Inc (NYSE:TISI), reported purchases totaling 5,000 shares valued at $79,991 in a Form 4 filing with the SEC. The trades occurred in two sessions on March 23 and March 24, 2026, at weighted average prices of $15.21 and $16.31 respectively. After these transactions, Stenger directly holds 14,890 shares. The purch…

Rigetti Computing Intends to Invest $100 Million in UK to Accelerate Quantum Computing Development

Rigetti Computing Intends to Invest $100 Million in UK to Accelerate Quantum Computing Development

Rigetti Computing announced plans to invest up to $100 million in the UK to accelerate quantum computing development, aiming to deploy a quantum computer with over 1,000 qubits within 3 to 4 years. This marks Rigetti's first major investment outside the US and aligns with the UK government's £2 billion quantum computing initiative. The company high…

Minerva Neurosciences Presents Data from its Open-label Safety Trial Evaluating Roluperidone Co-administered with Olanzapine at SIRS 2026

Minerva Neurosciences Presents Data from its Open-label Safety Trial Evaluating Roluperidone Co-administered with Olanzapine at SIRS 2026

Minerva Neurosciences announced data from its open-label safety trial evaluating the co-administration of roluperidone and olanzapine. The study showed no significant safety, pharmacokinetic, or pharmacodynamic issues, supporting continued development. The company is now enrolling a confirmatory Phase 3 trial with topline data expected in the secon…

Firefly Aerospace Supports U.S. Space Force VICTUS DIEM Exercise

Firefly Aerospace Supports U.S. Space Force VICTUS DIEM Exercise

Firefly Aerospace, a U.S.-based space and defense technology company, supported Lockheed Martin and the U.S. Space Force in the VICTUS DIEM exercises focusing on rapid spacecraft processing and launch capabilities. The exercises demonstrated spacecraft arrival, integration, and launch operations within stringent timelines under simulated threat con…

WidePoint Reports Fourth Quarter and Full Year 2025 Financial Results

WidePoint Reports Fourth Quarter and Full Year 2025 Financial Results

WidePoint Corporation reported fourth quarter and full year 2025 results showing revenue growth compared to the prior year. The company achieved its 34th consecutive quarter of positive adjusted EBITDA and 9th quarter of positive free cash flow. Significant contract wins and backlog totaling over $220 million position WidePoint for future growth, p…

Artelo Biosciences Expands ART27.13 Development as a Potential Companion Therapy to GLP-1 Treatments

Artelo Biosciences Expands ART27.13 Development as a Potential Companion Therapy to GLP-1 Treatments

Artelo Biosciences announces strategic expansion of ART27.13 development targeting preservation of muscle mass in patients receiving GLP-1 receptor agonist therapy. Supported by clinical and preclinical data, patent filing, and initiation of new studies, the company aims to position ART27.13 as a differentiated companion therapy in the fast-growing…

Stran & Company Reports 40.6% Year-Over-Year Revenue Growth to $116.2 Million for the 2025 Fiscal Year

Stran & Company Reports 40.6% Year-Over-Year Revenue Growth to $116.2 Million for the 2025 Fiscal Year

Stran & Company, Inc. reported strong fiscal 2025 financial results with $116.2 million in sales, a 40.6% increase from 2024, and positive EBITDA of $0.2 million compared to a loss in the prior year. Revenue growth was driven by 12.9% organic growth in the core promotional products segment and a significant sales increase from the acquired Gander G…

Burke & Herbert Financial Services Corp. and LINKBANCORP, Inc. Announce Receipt of Shareholder Approval for Merger

Burke & Herbert Financial Services Corp. and LINKBANCORP, Inc. Announce Receipt of Shareholder Approval for Merger

Burke & Herbert Financial Services Corp. and LINKBANCORP, Inc., both Nasdaq-listed US community bank holding companies, have received shareholder approval to merge, with Burke & Herbert as the surviving entity. The merger aims to enhance financial solutions across multiple states in the Mid-Atlantic region and is subject to regulatory approvals and…

SeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

SeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

SeaStar Medical reported 2025 financial results highlighting significant progress in clinical trials for its Selective Cytopheretic Device (SCD) therapy for Acute Kidney Injury (AKI), expanding the QUELIMMUNE therapy's adoption in top pediatric hospitals, and preparing for FDA approvals. The company achieved over 50% enrollment in the pivotal NEUTR…

Equillium Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate and Clinical Highlights

Equillium Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate and Clinical Highlights

Equillium, a clinical-stage biotech focused on immunobiology therapies for autoimmune and inflammatory diseases, reported Q4 and full year 2025 financial results. The company completed two financings totaling $85 million, bolstering cash reserves to $30.3 million as of year-end plus $35 million raised in March 2026, expected to fund operations thro…